A Radical Treatment for Insulin Pricing

A Radical Treatment for Insulin PricingA private, nonprofit company recently announced that it intends to bypass the traditional supply chain and sell interchangeable biosimilar insulin products at substantially reduced prices.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine Jg. 386; H. 23; S. 2157 - 2159
1. Verfasser:	Dafny, Leemore S.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Massachusetts Medical Society 09.06.2022
Schlagworte:	and the FDA Biological products Brand names Cost control Cost of Health Care Devices Diabetes Drug stores Drugs Endocrinology Generic drugs Health Policy Insulin Patients Pharmaceutical industry Pharmacy Prices Profits Rebates Supply chains United States > US Health Policy Medicine and Business Drug and Device Safety
ISSN:	0028-4793, 1533-4406, 1533-4406
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!